Form 4: Immatics Director Reicin Acquires Stock Options

Immatics N.V. Director Alise Reicin acquired 48,000 stock options with an exercise price of $9.09, vesting on June 16, 2026.

Summary

• Alise Reicin, a Director at Immatics N.V., acquired 48,000 stock options.
• The options have an exercise price of $9.09 per share.
• These options are set to vest fully on June 16, 2026, which is the first anniversary of the grant date.
• The transaction was reported on June 18, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a standard compensation mechanism for a director rather than a significant new strategic development or financial performance indicator.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The exercise price of $9.09 suggests a potential upside for the options if the stock price increases.

Negatives

• The options have not yet vested, meaning they do not represent immediate ownership or value.
• The filing does not provide details on the rationale behind the option grant.

Risks

• The value of the stock options is contingent on the future performance of Immatics N.V.'s stock price.
• There is a risk that the stock price may not exceed the exercise price of $9.09 by the vesting date, rendering the options worthless.

Future Outlook

The acquisition of stock options by a director suggests a positive outlook on the company's future stock performance, as the options will only be valuable if the stock price appreciates beyond the exercise price by the vesting date.

Industry Context

StockSavvy.ai notes that insider option grants are common in the biotechnology and pharmaceutical sectors, often used as a long-term incentive for key personnel to align their interests with shareholders. The specific terms of this grant will be evaluated against industry norms for similar executive compensation packages.

Stakeholder Impact

• Shareholders: The grant of options to a director is a standard compensation practice. Its impact on shareholders depends on the company's future performance and the eventual exercise of these options.

Next Steps

• The stock options will vest on June 16, 2026.
• The reporting person may exercise the options if the stock price is above $9.09 after vesting.

Key Dates

Keywords

Immatics N.V., IMTX, Form 4, Stock Options, Director, Beneficial Ownership, Securities, Insider Trading, Grant Date, Vesting